Skip to content
NewsBlazeIN – Lifestyle
Author:
BillionToOne
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
September 2, 2026
BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin
September 1, 2026
/C O R R E C T I O N — BillionToOne/
August 19, 2026
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
August 18, 2026
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
July 20, 2026
BillionToOne’s Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
June 29, 2026